Why These 15 Defensive Stocks Are Surging In 2025

Page 11 of 14

4. Hims & Hers Health Inc (NYSE:HIMS)

Number of Hedge Fund Holders In Q4 2024: 38

Hims & Hers Health Inc (NYSE:HIMS) operates a telehealth platform that connects consumers to licensed healthcare professionals for personalized medical care and wellness products.

The stock is up significantly so far in 2025, as the company reported strong financial results for 2024. Revenue reached $1.5 billion, up 69% from the previous year. Net income hit $126 million, and subscribers grew to 2.2 million, a 45% increase.

The company’s expansion into high-demand areas like weight loss has fueled excitement. It offers compounded GLP-1 medications, which are popular for obesity management. These drugs have drawn attention amid shortages of branded versions. Hims & Hers stepped in to meet this need. The weight loss segment has become a key growth driver.

Plus, 2025 guidance has boosted confidence. It projects revenue between $2.3 billion and $2.4 billion. Adjusted EBITDA is expected to range from $270 million to $320 million. These forecasts signal continued momentum. Analysts and investors see a clear path to further gains.

The consensus price target of $37.31 implies 18.6% upside.

HIMS stock is up 30.23% year-to-date.

Page 11 of 14